ATP6V1E2
gene geneOn this page
Also known as MGC9341VMA4ATP6E1
Summary
ATP6V1E2 (ATPase H+ transporting V1 subunit E2, HGNC:18125) is a protein-coding gene on chromosome 2p21, encoding V-type proton ATPase subunit E 2 (Q96A05). Subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons.
Predicted to enable proton-transporting ATPase activity, rotational mechanism. Predicted to be involved in regulation of macroautophagy. Predicted to act upstream of or within proton transmembrane transport. Predicted to be located in cytosol. Predicted to be part of proton-transporting two-sector ATPase complex, catalytic domain.
Source: NCBI Gene 90423 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 48 total
- MANE Select transcript:
NM_001318063
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18125 |
| Approved symbol | ATP6V1E2 |
| Name | ATPase H+ transporting V1 subunit E2 |
| Location | 2p21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC9341, VMA4, ATP6E1 |
| Ensembl gene | ENSG00000250565 |
| Ensembl biotype | protein_coding |
| OMIM | 617385 |
| Entrez | 90423 |
Gene structure
Transcript identifiers
Ensembl transcripts: 22 — 18 protein_coding, 4 protein_coding_CDS_not_defined
ENST00000306448, ENST00000505245, ENST00000522219, ENST00000522587, ENST00000524188, ENST00000524249, ENST00000890126, ENST00000890127, ENST00000890128, ENST00000890129, ENST00000890130, ENST00000890131, ENST00000890132, ENST00000890133, ENST00000923418, ENST00000923419, ENST00000923420, ENST00000923421, ENST00000965787, ENST00000965788, ENST00000965789, ENST00000965790
RefSeq mRNA: 4 — MANE Select: NM_001318063
NM_001318063, NM_001371281, NM_001371282, NM_001371283
CCDS: CCDS1826
Canonical transcript exons
ENST00000522587 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001169252 | 46511847 | 46512812 |
| ENSE00002079314 | 46536611 | 46536703 |
| ENSE00002093048 | 46535813 | 46535927 |
| ENSE00002097559 | 46541390 | 46541453 |
| ENSE00002135498 | 46542217 | 46542577 |
Expression profiles
Bgee: expression breadth ubiquitous, 204 present calls, max score 95.88.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.3611 / max 62.2497, expressed in 1243 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 28188 | 2.2572 | 1226 |
| 28186 | 0.0534 | 3 |
| 28187 | 0.0505 | 9 |
Top tissues by expression
232 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 95.88 | gold quality |
| right testis | UBERON:0004534 | 88.25 | gold quality |
| left testis | UBERON:0004533 | 88.17 | gold quality |
| testis | UBERON:0000473 | 86.67 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.95 | gold quality |
| islet of Langerhans | UBERON:0000006 | 84.08 | gold quality |
| leukocyte | CL:0000738 | 81.66 | gold quality |
| monocyte | CL:0000576 | 81.64 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.96 | gold quality |
| adult organism | UBERON:0007023 | 80.49 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 80.33 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 79.48 | gold quality |
| muscle of leg | UBERON:0001383 | 79.45 | gold quality |
| granulocyte | CL:0000094 | 79.42 | gold quality |
| ventricular zone | UBERON:0003053 | 79.25 | gold quality |
| gastrocnemius | UBERON:0001388 | 79.20 | gold quality |
| pancreas | UBERON:0001264 | 77.92 | gold quality |
| right frontal lobe | UBERON:0002810 | 77.56 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 77.51 | gold quality |
| right adrenal gland | UBERON:0001233 | 77.41 | gold quality |
| spinal cord | UBERON:0002240 | 77.33 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 77.23 | gold quality |
| prefrontal cortex | UBERON:0000451 | 77.20 | gold quality |
| putamen | UBERON:0001874 | 77.09 | gold quality |
| amygdala | UBERON:0001876 | 76.83 | gold quality |
| caudate nucleus | UBERON:0001873 | 76.81 | gold quality |
| left adrenal gland | UBERON:0001234 | 76.76 | gold quality |
| nucleus accumbens | UBERON:0001882 | 76.72 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 76.44 | gold quality |
| calcaneal tendon | UBERON:0003701 | 76.31 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.57 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Rat vacuolar H(+)ATPase associates with NHE-RF (Na(+)/H(+) exchanger regulatory factor); the E subunit was co-immunoprecipitated from rat kidney cytosol with NHE-RF antibodies. (PMID:10748165)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | atp6v1e1a | ENSDARG00000014085 |
| danio_rerio | atp6v1e1b | ENSDARG00000030694 |
| mus_musculus | Atp6v1e2 | ENSMUSG00000053375 |
| rattus_norvegicus | Atp6v1e2 | ENSRNOG00000015566 |
| drosophila_melanogaster | Vha26 | FBGN0283535 |
| caenorhabditis_elegans | WBGENE00006917 |
Paralogs (1): ATP6V1E1 (ENSG00000131100)
Protein
Protein identifiers
V-type proton ATPase subunit E 2 — Q96A05 (reviewed: Q96A05)
Alternative names: Vacuolar proton pump subunit E 2
All UniProt accessions (2): Q96A05, A0A140VKA8
UniProt curated annotations — full annotation on UniProt →
Function. Subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons. V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment.
Subunit / interactions. V-ATPase is a heteromultimeric enzyme made up of two complexes: the ATP-hydrolytic V1 complex and the proton translocation V0 complex. The V1 complex consists of three catalytic AB heterodimers that form a heterohexamer, three peripheral stalks each consisting of EG heterodimers, one central rotor including subunits D and F, and the regulatory subunits C and H. The proton translocation complex V0 consists of the proton transport subunit a, a ring of proteolipid subunits c9c’’, rotary subunit d, subunits e and f, and the accessory subunits ATP6AP1/Ac45 and ATP6AP2/PRR.
Tissue specificity. Testis specific.
Similarity. Belongs to the V-ATPase E subunit family.
RefSeq proteins (4): NP_001304992, NP_001358210, NP_001358211, NP_001358212 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002842 | ATPase_V1_Esu | Family |
| IPR038495 | ATPase_E_C | Homologous_superfamily |
Pfam: PF01991
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96A05-F1 | 93.07 | 0.86 |
Function
Pathways and Gene Ontology
Reactome pathways
5 pathways
| ID | Pathway |
|---|---|
| R-HSA-1222556 | ROS and RNS production in phagocytes |
| R-HSA-77387 | Insulin receptor recycling |
| R-HSA-917977 | Transferrin endocytosis and recycling |
| R-HSA-9639288 | Amino acids regulate mTORC1 |
| R-HSA-983712 | Ion channel transport |
MSigDB gene sets: 85 (showing top):
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR, GOBP_REGULATION_OF_AUTOPHAGY, REACTOME_INNATE_IMMUNE_SYSTEM, GOCC_SECRETORY_GRANULE, CAGCTG_AP4_Q5, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_MACROAUTOPHAGY, GOBP_REGULATION_OF_CATABOLIC_PROCESS, HP1SITEFACTOR_Q6, WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN, GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, WEBER_METHYLATED_LCP_IN_SPERM_UP, GOBP_TRANSMEMBRANE_TRANSPORT, KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION, CP2_01
GO Biological Process (3): regulation of macroautophagy (GO:0016241), monoatomic ion transport (GO:0006811), proton transmembrane transport (GO:1902600)
GO Molecular Function (2): proton-transporting ATPase activity, rotational mechanism (GO:0046961), protein binding (GO:0005515)
GO Cellular Component (3): acrosomal vesicle (GO:0001669), cytosol (GO:0005829), proton-transporting two-sector ATPase complex, catalytic domain (GO:0033178)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Innate Immune System | 1 |
| Signaling by Insulin receptor | 1 |
| Iron uptake and transport | 1 |
| Cellular response to starvation | 1 |
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of autophagy | 1 |
| macroautophagy | 1 |
| transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| proton transmembrane transporter activity | 1 |
| ATPase-coupled monoatomic cation transmembrane transporter activity | 1 |
| ATPase activity, coupled to transmembrane movement of ions, rotational mechanism | 1 |
| binding | 1 |
| secretory granule | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| proton-transporting two-sector ATPase complex | 1 |
| membrane protein complex | 1 |
Protein interactions and networks
STRING
938 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ATP6V1E2 | ATP6V1G3 | Q96LB4 | 886 |
| ATP6V1E2 | ATP6V1G2 | O95670 | 875 |
| ATP6V1E2 | ATP6V1G1 | O75348 | 875 |
| ATP6V1E2 | ATP6V1B1 | P15313 | 863 |
| ATP6V1E2 | ATP6V1B2 | P21281 | 863 |
| ATP6V1E2 | ATP6V1C2 | Q8NEY4 | 851 |
| ATP6V1E2 | ATP6V1D | Q9Y5K8 | 842 |
| ATP6V1E2 | ATP6V1C1 | P21283 | 832 |
| ATP6V1E2 | ATP6V1H | Q9UI12 | 832 |
| ATP6V1E2 | ATP6V0D1 | P12953 | 824 |
| ATP6V1E2 | ATP6V0A2 | Q9Y487 | 810 |
| ATP6V1E2 | ATP6V0A1 | Q93050 | 796 |
| ATP6V1E2 | ATP6V0A4 | Q9HBG4 | 795 |
| ATP6V1E2 | ATP6V1F | Q16864 | 794 |
| ATP6V1E2 | ATP6V0D2 | Q8N8Y2 | 790 |
IntAct
40 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ATP6V1G1 | ATP6V1E2 | psi-mi:“MI:0915”(physical association) | 0.830 |
| ATP6V1E2 | ATP6V1G1 | psi-mi:“MI:0915”(physical association) | 0.830 |
| ATP6V1G2 | ATP6V1E2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ATP6V1C2 | ATP6V1G1 | psi-mi:“MI:0914”(association) | 0.640 |
| ATP6V1E2 | BBLN | psi-mi:“MI:0915”(physical association) | 0.560 |
| BBLN | ATP6V1E2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RASSF10 | ATP6V1E2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MESD | ATP6V1E2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ATP6V0A1 | ATP6V1G1 | psi-mi:“MI:0914”(association) | 0.530 |
| ATP6V0A4 | ATP6AP2 | psi-mi:“MI:0914”(association) | 0.530 |
| ATP6V1B2 | ATP6V1G1 | psi-mi:“MI:0914”(association) | 0.530 |
| ATP6V1G2 | ATP6V1B1 | psi-mi:“MI:0914”(association) | 0.530 |
| MAPT | NCAN | psi-mi:“MI:0914”(association) | 0.350 |
| ATP6V1C2 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| ATP6V1B1 | ATP6V1G1 | psi-mi:“MI:0914”(association) | 0.350 |
| ATP6AP2 | A2M | psi-mi:“MI:0914”(association) | 0.350 |
| ATP6V0A2 | ATP6V1G1 | psi-mi:“MI:0914”(association) | 0.350 |
| ATP6V1H | ATP6V1B1 | psi-mi:“MI:0914”(association) | 0.350 |
| SMPD2 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| ATP6V1G1 | ATP6V1E2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ATP6V1G2 | ATP6V1E2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (31): ATP6V1E2 (Two-hybrid), ATP6V1E2 (Two-hybrid), ATP6V1E2 (Affinity Capture-MS), ATP6V1E2 (Affinity Capture-MS), ATP6V1E2 (Two-hybrid), ATP6V1G1 (Two-hybrid), ATP6V1E2 (Affinity Capture-MS), ATP6V1E2 (Affinity Capture-MS), ATP6V1E2 (Two-hybrid), ATP6V1E2 (Two-hybrid), ATP6V1E2 (Two-hybrid), ATP6V1E2 (Two-hybrid), ATP6V1E2 (Affinity Capture-MS), ATP6V1E2 (Proximity Label-MS), ATP6V1E2 (Affinity Capture-MS)
ESM2 similar proteins: A1CQI3, A3KNK7, B0WAM5, B0WG73, B2RYZ5, B3MQ24, B3NUB6, B4H2S0, B4IK33, B4JLC3, B4L1Z8, B4M6M6, B4NUB3, B4PY93, B5XC71, B5XGH3, P45437, Q08DS5, Q17MZ8, Q1DRC2, Q1HQY6, Q1JQD4, Q29IN4, Q2F5R8, Q32LB7, Q3KPT5, Q3UQ44, Q498D9, Q4H3N8, Q5BDL9, Q5M759, Q5RC82, Q68EW7, Q6DH42, Q6NQ54, Q6NQH4, Q6P255, Q7QIL8, Q803N9, Q8TF65
Diamond homologs: O00780, O13687, O23948, O94072, P0CAN7, P11019, P22203, P31402, P36543, P50518, P54611, Q01278, Q32LB7, Q39258, Q40272, Q41396, Q4R761, Q6PCU2, Q95X44, Q96A05, Q9C9Z8, Q9D593, Q9MB46, Q9SWE7, Q9U1G5, O27039, Q3J9F2, O06501, Q5JDS0, Q9UXU4, A6UT32, C6A5F1
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| ATP6V1E2 | “form complex” | V-ATPase | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 19 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Insulin receptor recycling | 9 | 244.7× | 1e-19 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | 5 | 239.9× | 9e-11 |
| Transferrin endocytosis and recycling | 9 | 236.8× | 1e-19 |
| ROS and RNS production in phagocytes | 9 | 215.9× | 2e-19 |
| Amino acids regulate mTORC1 | 6 | 85.9× | 3e-10 |
| Ion channel transport | 9 | 61.7× | 3e-14 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| synaptic vesicle lumen acidification | 7 | 344.9× | 3e-15 |
| vacuolar acidification | 7 | 269.9× | 1e-14 |
| regulation of macroautophagy | 8 | 124.5× | 3e-14 |
| proton transmembrane transport | 7 | 115.0× | 3e-12 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
48 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
247 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:46512820:A:T | acceptor_gain | 1.0000 |
| 2:46543185:GCAG:G | donor_gain | 1.0000 |
| 2:46543187:AGGT:A | donor_loss | 1.0000 |
| 2:46543189:G:GG | donor_gain | 1.0000 |
| 2:46543189:GTA:G | donor_loss | 1.0000 |
| 2:46512819:CAG:C | acceptor_gain | 0.9900 |
| 2:46543184:CGCAG:C | donor_gain | 0.9900 |
| 2:46543185:GCAGG:G | donor_gain | 0.9900 |
| 2:46543186:CAG:C | donor_gain | 0.9900 |
| 2:46543187:AG:A | donor_gain | 0.9900 |
| 2:46543188:GG:G | donor_gain | 0.9900 |
| 2:46543190:T:G | donor_loss | 0.9900 |
| 2:46512808:CTCAG:C | acceptor_gain | 0.9700 |
| 2:46512810:CAG:C | acceptor_gain | 0.9700 |
| 2:46512812:GC:G | acceptor_loss | 0.9700 |
| 2:46512813:C:CA | acceptor_loss | 0.9700 |
| 2:46512813:C:CC | acceptor_gain | 0.9700 |
| 2:46512821:G:GC | acceptor_gain | 0.9700 |
| 2:46512833:A:C | acceptor_gain | 0.9700 |
| 2:46512814:T:A | acceptor_loss | 0.9600 |
| 2:46512818:CCAG:C | acceptor_gain | 0.9600 |
| 2:46512821:G:C | acceptor_gain | 0.9600 |
| 2:46512827:A:T | acceptor_gain | 0.9600 |
| 2:46512826:C:CT | acceptor_gain | 0.9500 |
| 2:46512815:A:C | acceptor_gain | 0.9400 |
| 2:46519779:C:CT | donor_gain | 0.9300 |
| 2:46519780:T:TT | donor_gain | 0.9300 |
| 2:46512809:TCAG:T | acceptor_gain | 0.9200 |
| 2:46512810:CAGC:C | acceptor_gain | 0.9200 |
| 2:46512819:C:CT | acceptor_loss | 0.9200 |
AlphaMissense
1487 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:46512658:G:C | F18L | 0.996 |
| 2:46512658:G:T | F18L | 0.996 |
| 2:46512660:A:G | F18L | 0.996 |
| 2:46512645:C:G | A23P | 0.992 |
| 2:46512612:C:G | A34P | 0.989 |
| 2:46512598:A:C | F38L | 0.984 |
| 2:46512598:A:T | F38L | 0.984 |
| 2:46512600:A:G | F38L | 0.984 |
| 2:46512563:C:G | R50P | 0.983 |
| 2:46512633:C:G | A27P | 0.978 |
| 2:46512618:C:G | A32P | 0.975 |
| 2:46512477:C:G | A79P | 0.973 |
| 2:46512578:A:G | L45P | 0.972 |
| 2:46512581:C:G | R44P | 0.961 |
| 2:46512116:C:G | R199P | 0.960 |
| 2:46512663:C:G | A17P | 0.958 |
| 2:46512667:C:A | M15I | 0.958 |
| 2:46512667:C:G | M15I | 0.958 |
| 2:46512667:C:T | M15I | 0.958 |
| 2:46512586:T:A | K42N | 0.956 |
| 2:46512586:T:G | K42N | 0.956 |
| 2:46512659:A:C | F18C | 0.952 |
| 2:46512077:C:G | R212P | 0.950 |
| 2:46512659:A:G | F18S | 0.946 |
| 2:46512495:A:G | S73P | 0.945 |
| 2:46512130:A:C | N194K | 0.944 |
| 2:46512130:A:T | N194K | 0.944 |
| 2:46512113:A:G | L200P | 0.940 |
| 2:46512345:C:G | G123R | 0.939 |
| 2:46512308:C:G | R135P | 0.938 |
dbSNP variants (sampled 300 via entrez): RS1000118632 (2:46511785 C>T), RS1000162926 (2:46532866 C>G), RS1000378538 (2:46531624 A>G), RS1000486971 (2:46537646 G>C), RS1000506497 (2:46525319 G>A), RS1000572358 (2:46526588 T>C), RS1000639419 (2:46533063 A>C,T), RS1000660005 (2:46530437 C>A), RS1000693159 (2:46538739 T>C), RS1000744851 (2:46539034 C>T), RS1000773624 (2:46536550 G>A,C), RS1000837922 (2:46537977 GA>G,GAA), RS1000878723 (2:46522166 T>C), RS1000928138 (2:46541689 G>A), RS1000944557 (2:46518431 G>A,T)
Disease associations
OMIM: gene MIM:617385 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005025_31 | Anti-saccade response | 8.000000e-06 |
| GCST005027_2 | Anti-saccade error rate in psychotic disorders | 2.000000e-07 |
| GCST010002_390 | Refractive error | 1.000000e-11 |
| GCST010697_51 | Cortical surface area (min-P) | 4.000000e-12 |
| GCST010698_64 | Subcortical volume (min-P) | 3.000000e-09 |
| GCST010699_93 | Brain morphology (min-P) | 1.000000e-12 |
| GCST010700_22 | Cortical thickness (MOSTest) | 9.000000e-11 |
| GCST010701_108 | Cortical surface area (MOSTest) | 4.000000e-12 |
| GCST010702_134 | Subcortical volume (MOSTest) | 2.000000e-14 |
| GCST010703_146 | Brain morphology (MOSTest) | 5.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006874 | antisaccade response measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — V-type ATPase
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cisplatin | affects expression, decreases expression | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, increases methylation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| ICG 001 | increases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | increases expression | 1 |
| Decitabine | affects expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Phenobarbital | affects expression | 1 |
| Quercetin | increases expression | 1 |
| Rotenone | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.